Company research
Cyclo Therapeutics, Inc.
CIK 922247Updated Sep 24, 2026
Securities
Historical securities (1)
CYTHW · NASDAQ · warrant · closed Mar 27, 2025Name history
CTD HOLDINGS INC · through Sep 30, 2019CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC · through Mar 30, 2000
CYTHW price & chart
Historical security
This listing closed Mar 27, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
15-12G filing
25-NSE - filed by Nasdaq Stock Market LLC regarding Cyclo Therapeutics, Inc.
Completion of Acquisition or Disposition of Assets · Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Material Modification to Rights of Security Holders · Changes in Control of Registrant · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 2.01, 3.01, 3.03, 5.01, 5.02, 7.01, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
Financials
FY 2023 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 13,247,538Source | 4,215,213Source | 19,520,833Source | 14,187,964Source |
| Property, Plant and Equipment, NetUSD | 38,332Source | 55,188Source | 59,583Source | 53,910Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 9,246,592Source | 1,543,418Source | 16,612,711Source | 12,846,113Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 122,379Source | 54,991Source | 493,113Source | 71,017Source |
| Inventory, NetUSD | 254,352Source | 254,491Source | 227,437Source | 237,909Source |
| Assets, CurrentUSD | 12,318,257Source | 4,158,555Source | 19,436,335Source | 14,050,237Source |
| Operating Lease, Right-of-Use AssetUSD | 890,949Source | 1,470Source | 17,636Source | 34,011Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 2,856Source | 849Source | 841Source | 477Source |
| Additional Paid in CapitalUSD | 88,610,832Source | 64,533,074Source | 64,019,513Source | 44,513,841Source |
| Retained Earnings (Accumulated Deficit)USD | -83,856,681Source | -63,799,379Source | -48,348,491Source | -34,061,836Source |
| Stockholders' Equity Attributable to ParentUSD | 4,757,007Source | 734,544Source | 15,671,863Source | 10,452,482Source |
| Liabilities and EquityUSD | 13,247,538Source | 4,215,213Source | 19,520,833Source | 14,187,964Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 8,468,047Source | 3,480,669Source | 3,830,936Source | 3,672,553Source |
| Operating Lease, Liability, CurrentUSD | 1,010,631Source | 0Source | 19,245Source | 17,483Source |
| Accounts Payable, CurrentUSD | 4,856,530Source | — | — | — |
| Operating Lease, Liability, NoncurrentUSD | 22,484Source | — | 0Source | 18,434Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 230,000Source | 4,000Source | 83,000Source | 2,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 19,276Source | 19,481Source | 16,827Source | 12,763Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | 354,056Source | — | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 67,388Source | -427,850Source | 444,023Source | -72,412Source |
| Increase (Decrease) in InventoriesUSD | 52,783Source | 27,054Source | -10,472Source | -4,721Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -16,185,026Source | -15,114,241Source | -15,005,298Source | -8,540,185Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,420Source | 38,170Source | 14,822Source | -14,048Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 2,420Source | 15,086Source | 22,500Source | 53,127Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 23,890,620Source | 6,778Source | 18,757,074Source | 18,616,627Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 7,703,174Source | -15,069,293Source | 3,766,598Source | 10,062,394Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 10,056Source | 0Source | 3,525Source | 528Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 124,998Source | 271,308Source |
| DepreciationUSD | 19,276Source | 19,481Source | 16,827Source | — |
| Depreciation, NonproductionUSD | 19,276Source | 19,481Source | 16,827Source | 12,763Source |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 158,524Source | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Inventory Write-downUSD | 52,922Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -20,057,302Source | -15,450,888Source | -14,286,655Source | -8,941,603Source |
| Nonoperating Income (Expense)USD | -7,245Source | — | 3,405Source | — |
| Operating Lease, ExpenseUSD | 28,353Source | 16,166Source | 17,636Source | 17,006Source |
| Other Nonoperating Income (Expense)USD | — | 12,474Source | — | — |
| Proceeds from Issuance of Common StockUSD | 9,739,040Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | 1,478Source | — | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 1,076,405Source | 1,375,760Source | 1,585,756Source | 903,376Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -20,050,057Source | -15,621,886Source | -14,290,060Source | -8,961,405Source |
| Other Nonoperating Income (Expense)USD | — | 12,474Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -20,057,302Source | -15,450,888Source | -14,286,655Source | -8,941,603Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -20,057,302Source | -15,450,888Source | -14,286,655Source | -8,941,603Source |
| Earnings Per Share, BasicUSD per share | -1.23Source | -1.83Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 16,329,713Source | 8,439,177Source | — | — |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 21,042,095Source | 16,997,646Source | 15,875,816Source | 9,864,781Source |
| Gross ProfitUSD | 992,038Source | — | — | — |
| Nonoperating Income (Expense)USD | -7,245Source | — | 3,405Source | — |
| Operating Lease, ExpenseUSD | 28,353Source | 16,166Source | 17,636Source | 17,006Source |
| Research and Development ExpenseUSD | 14,181,769Source | 8,999,543Source | 9,153,780Source | 6,096,445Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 1,076,405Source | 1,375,760Source | 1,585,756Source | 903,376Source |